相关实验视频
Updated: Jan 17, 2026

08:51
Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
8.9K
潘托酸激酶4通过调节协酶A和谷氨酸氨基溶解来控制T细胞增殖的脂质合成
Jeong-Ryul Hwang1,2, Chi Thi Ngoc Nguyen1, Gwanghoon Ko1
1College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University, Seoul, Republic of Korea.
Signal transduction and targeted therapy
|September 17, 2025
概括
CD28信号通路调节PANK4,影响新的脂质合成和CD4+T细胞增殖. 在炎症模型中,PANK4缺乏会增强T细胞扩张.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 代谢途径 代谢途径
背景情况:
- 通过TCR和CD28信号的T细胞激活驱动炎症反应.
- CD28-PI3K通路对于T细胞代谢重编程和增殖至关重要.
- 新生脂质合成支持免疫反应期间的T细胞扩张.
研究的目的:
- 研究 PANK4 在 CD4+ T 细胞增殖中的作用.
- 通过CD28信号来阐明PANK4的调节机制.
- 评估针对T细胞介导疾病中PANK4的治疗潜力.
主要方法:
- 在CD4+T细胞中研究了PANK4调控.
- 分析了新的脂质合成和代谢重编程.
- 使用实验性结肠炎和流感A病毒感染的小鼠模型.
主要成果:
- CD28信号通过PDK1负面调节PANK4,控制脂质合成.
- 缺乏Pank4的T细胞表现出增加的协酶A合成和谷氨酸溶解.
- 在炎症期间,Pank4缺乏会在体内增强CD4+T细胞扩张.
结论:
- PANK4依赖的de novo脂质合成对于T细胞受体/CD28诱导的CD4+T细胞增殖至关重要.
- PANK4是T细胞代谢适应和扩张的关键调节者.
- 向PANK4可能提供一种策略,以调节 CD4+ T 细胞在炎症条件下的反应.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Lipid Catabolism
862
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
862
Phosphoinositides and PIPs
10.1K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K

